Tag Archives: HEA

UBTECH announces global debut of intelligent healthcare robots and solutions

SHENZHEN, China, Sept. 3, 2022 /PRNewswire/ — On August 31, UBTECH ROBOTICS CORP LTD hosted a forum on “The Integration of the High Technology and the Elderly-care Service Industry ” together with the launching of “The Global Strategy of Smart Elderly-care of UBTECH ROBOTICS CORP LTD”. Experts and professionals in the healthcare and elderly-care service industry came together to discuss the development and implementation of a technology-driven smart elderly-care system and shared the valuable experience and insights within the domain.

At the event, UBTECH announced its strategy of creating a smart elderly-care system with several sub-systems within specific elderly-care scenarios. They also launched several robotics products for the healthcare and elderly-care domain. In addition, UBTECH announced key strategic collaboration agreements with China Merchants Health Care, Medical Care Service Company Inc (MCS) in Japan (A joint venture company to be established this month), and China Academy of Transportation Sciences Group.

The forum on “The Integration of the High Technology and the Elderly-care Service Industry ” and the launching event of “The Global Strategy of Smart Elderly-care of UBTECH ROBOTICS CORP LTD”
The forum on “The Integration of the High Technology and the Elderly-care Service Industry ” and the launching event of “The Global Strategy of Smart Elderly-care of UBTECH ROBOTICS CORP LTD”

UBTECH combines intelligent robots and Artificial Intelligence (AI) technology, coordinated by the UBTECH Smart Elderly-care Cloud-based Platform, for the aged group. The whole system provides nursing services for senior citizens living at home or in community centers. The cloud platform-based solution focuses on six key scenarios: services management, daily care management, security and health monitoring, memory-loss prevention, emotional support and rehabilitation. The goal of the system is to create a comprehensive system with high reliability and security to provide the elderly a happy, healthy, and high-quality way of living.

Huan Tan, Co-Chief Technology Officer, UBTECH ROBOTICS CORP LTD and General Manager, UBTECH Healthcare Business Unit, introduced the strategy and solutions for the smart elderly-care service
Huan Tan, Co-Chief Technology Officer, UBTECH ROBOTICS CORP LTD and General Manager, UBTECH Healthcare Business Unit, introduced the strategy and solutions for the smart elderly-care service

Huan Tan (Co-Chief Technology Officer, UBTECH ROBOTICS CORP LTD and General Manager, UBTECH Healthcare Business Unit,), introduced how the company has been developing and integrating AI, robotics, and other high-tech approaches to improve the quality of life for our senior citizens. They apply this technology in the elderly-care industry to create new services, develop a new ecosystem, and generate substantially new values to the industry. The new services are brought by new technology, including the active interaction and companionship, autonomous navigation for uninterrupted and automated door-to-door care provider, the continuous monitoring of personal and environmental safety, precise evaluations, intervention plans, and rehabilitation exercises for the people with the cognitive, psychological and physical disabilities. The new ecosystem integrates robots and smart devices into an elderly-care service system that enables collaborative operations conducted by humans, robots, machines, devices, and IT infrastructure. These robots are regarded as  intelligent service providers, a key  innovation that can significantly improve the reliability and quality healthcare services for the elderly. Based on the new services and new ecosystem, new values are generated to the elderly-care service industry and the end-users with connected senior-care services in facilities, communities, and homes. The operations will be largely improved for the facilities and communities, whereas the senior people will receive some more precise, friendly, and active services, which bring high -quality lives than ever.

A resident of a senior-care facility is performing personalized rehabilitation exercises with the help of UBTECH Walking Assist Robot - Wassi
A resident of a senior-care facility is performing personalized rehabilitation exercises with the help of UBTECH Walking Assist Robot – Wassi

The UBTECH Healthcare Business Unit showcased five innovative and powerful service robots: Walking Assist Robot-Wassi, Containerized Delivery Robot-DR, Smart Wheelchair Robot – PathFynder, Open Shelf Delivery Robot-OSDR and Companion Robot-Welli. These robots directly address the challenges of the increasing shortage of caregivers, the fast-growing global aging populations, and the increasing demand for high-quality healthcare services, together with other hardware and software components within the smart elderly-care ecosystem. Additionally, UBTECH debuted a cloud-based Intelligent Elderly-care Service Platform, a “Super Brain”, that can coordinate services between service robots and IoT devices for the elderly-care service domain. These robots can operate safely in nursing homes, assisted living communities, hospitals, among other healthcare facilities, providing personalized services for senior citizens

A resident of a senior-care facility is experiencing the “barrier-free” travelling mobility service in a park, provided by UBTECH Smart Wheelchair Robot-PathFynder
A resident of a senior-care facility is experiencing the “barrier-free” travelling mobility service in a park, provided by UBTECH Smart Wheelchair Robot-PathFynder

To date, the integrated solution of UBTECH’s smart elderly-care service and the portfolio of the products has already been deployed, continuously providing services on several sites, including hospitals, assisted living facilities, nursing homes, and retirement communities. UBTECH also officially announced a partnership with China Merchants Health Care in Shenzhen, Xinkai Senior Care Facility in Shanghai, University of Hong Kong-Shenzhen Hospital and Taishan Sanatorium of Shandong Province.

At the launching ceremony of building the Ecological Community, UBTECH announced 12 partners, including the aforementioned China Merchants Health Care, Medical Care Service Company Inc (MCS) in Japan, and China Academy of Transportation Sciences Group, etc. The partners are from the elderly-care service providers, the operation owners of medical centers, and technology firms.

A resident at China Merchants Health Care in Shenzhen is interacting with the Companion Robot- Welli
A resident at China Merchants Health Care in Shenzhen is interacting with the Companion Robot- Welli

Yanhong Wen, China Merchants Health Care General Manager said “…, through the cooperation of companies like UBTECH, we expect robots to provide critical services to the senior citizens, including the screening of health risk, continuous monitoring of the health, assessment and evaluations of medical plans, the early warning and intervention, the active and interactive companionship, and the cognitive and physical rehabilitation, etc.” The two companies will continue to work together to build smart residential facilities to provide elderly-care services that meets the needs of the aging population in the community, to offer humanistic care, and to deliver comprehensive end-to-end service.

MCS Founder Takahashi Seiichi noted in a speech via remote video: “23 years ago, I started my first retirement facility in Japan. By 2017, we operated the largest number of dementia beds in Japan. Today, we operate a total of 322 healthcare facilities, including nursing homes and dementia treatment centers. Seven years ago, we opened a nursing home in Nantong, China, and subsequently launched new elderly care projects in other cities. Through the cooperation with UBTECH, we hope to combine the latest AI technology, intelligent robots and other products to transform the Chinese market.” Grace Wang, Director of the MCS Group and the General Manager of MCS China, mentioned that the partnership will enable a smarter solution to provide services to the senior citizens, in 3 key areas: nursing and technology, digital transformation, and prevention.

Yong Li, General Manager of the China Academy of Transportation Sciences Group, said in his speech: “I look forward to working with UBTECH on the integration and innovation of the smart transportation and travelling, and creating a commercialized example model for the smart travelling in public handicap-accessible transportation hubs throughout China. “

The elderly-care service industry contributes over 20% of the GDP in developed countries, e.g., the European countries and the United States, compared with only 7% in China, representing a huge potential of the market. The size of the market in China is expected to reach 10.29 trillion Chinese Yuan (approx. $1.5 trillion USD) by 2022. By leveraging a comprehensive integration with the elderly-care industry, the high technology-driven elderly care services will help further improve the quality of life and wellness of all families, and benefit the country’s aging population using innovative solutions.

Jian Zhou, the Founder, Chairman and CEO of UBTECH said, “We are committed to addressing the major challenges in communities of China, through our technological innovations, by delivering sustainable and real long-term values. In the elderly-care industry, we will leverage new and innovative AI-based solutions to better serve people and the communities, in which they reside, and accelerate the quality-focused growth of the intelligent healthcare sector.”

UBTECH has accumulated over 10 years of experience and expertise in AI and intelligent robotics technology. Throughout the ongoing journey, from the exploration of creating services for the seniors in 2017, establishing an R&D center in North America focusing on the healthcare sector in 2019 and a healthcare business unit in 2021 focusing on applying solutions in various elderly-care scenarios, to the releasing its global strategy for smart elderly-care in 2022, UBTECH has been a pioneer and leader in the smart healthcare sector. UBTECH is committed to the vision of transforming the healthcare industry and the sustainable development of the elderly-care economy with innovative technologies, together with the partners in the industry.

Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area

NANNING, China, Aug. 31, 2022 /PRNewswire/ — Recently, the lung CT image-aided diagnosis software developed by Guangxi Yizhun Intelligent Technology Co., Ltd. (“Yizhun”) in National Nanning Economic & Technological Development Area (“Area”) has been granted the registration certificate of class III medical devices (GXZZ20223210687).

Production workshop of Nanning Neptunus Health Industrial Park
Production workshop of Nanning Neptunus Health Industrial Park

Nanning’s investment promotion departments at all levels aim at creating biomedical industry clusters through high starting point planning and attraction of targeted investments, according to National Nanning Economic & Technological Development Area Management Committee. In the Area, the biomedical industry, involving the fields of production, inspection & testing, sales and distribution, continually expands in industrial scale and gradually improves in industrial chain. The approved “lung CT image-aided diagnosis software” is the first software in Guangxi province and the country’s eighth one with the registration certificate of class III AI medical devices and software, and the sixth in Guangxi province and the second in Nanning city to have received the certificate. This is another achievement of the city’s continuous optimization of services for moved-in enterprises and solid efforts in building up the biopharmaceutical industry.

In terms of precise investments, the Area has compiled a panorama of biopharmaceutical industry chain, positively brought in investments in the industry chain and industry clusters and introduced a batch of key projects such as Hainan Huluwa Pharmaceutical, Guangdong Yili Pharmaceutical, Yida Xiansheng, Sinopharm Group and Guangxi LiuYao Group, forming an industrial development pattern with biopharmaceuticals, traditional Chinese medicine, health care products, medical devices and modern pharmaceutical logistics as main fields. According to information, the Area is the major ground to develop the biopharmaceutical industry in the city, and there are currently 625 biopharmaceutical enterprises in the Area.

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=428269
   Caption: Production workshop of Nanning Neptunus Health Industrial Park

Source: National Nanning Economic & Technological Development Area Management Committee

Waterdrop Releases User Family Insurance Report

BEIJING, Aug. 26, 2022 /PRNewswire/ — Waterdrop Inc. (“Waterdrop”, the “Company” or “we”) (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently released the User Family Security Report. According to the survey of the users of Waterdrop Insurance Marketplace, the report shows that users’ insurance purchase behaviors are highly associated with families.

Users aged below 30 prefer to purchase insurance for parents

The Report shows that insurance purchasers aged below 30 pay more attention to their parent’s insurance, 49% of whom choose to purchase insurance for parent first.

Mr. Hui Teng, the chief actuary of Waterdrop, commented, “Most of the users aged below 30 were born in the 1990s and are only children. Many families have one child and four parents to support. They urgently need to plan pension and insurance services for themselves and their parents as early as possible.”

Users aged 31-40 prefer to purchase insurance for children

According to the Report, among users of all ages, those aged 31-40 saw the highest proportion, or 17%, when it comes to insurance purchases for children. Most of these users are the backbone of their families. Some of them just become parents, and some have had multiple children, paying more attention to children’s insurance.

But this doesn’t mean they ignore the insurance for themselves. The survey also shows, that 47% of the users aged 30-40 choose to purchase insurance for themselves first, 23% for parents, 17% for children, and 13% for spouses.

Users aged above 40 prefer to purchase insurance for “themselves or spouses” first. On a specific term, 61% of them choose to purchase insurance for themselves, 16% for spouses,14% for parents, and 9% for children.

According to the Report, the biggest number of users who purchase their first commercial insurance for themselves or family members are those aged 25-34, who represent over 31% of the total.

In the mind of users, the top 3 essential insurance coverage for families is “Medical insurance, Critical illness insurance, and Casualty insurance”. Medical insurance and critical illness insurance are the most basic insurance policies. Casualty insurance is also among the most popular entry-level insurance types.

The report also shows that more than 81% of users have three or more family insurance policies.

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Waterdrop’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-releases-user-family-insurance-report-301612959.html

Source: Waterdrop Inc.

Lunit Announces Financial Results for the First Half of 2022


  • Consolidated revenue in the second quarter of 2022 increased by 190% compared to same prior-year period
  • Total revenue for H1 2022 amounted to KRW 5.48 billion, or 82.5% of the total revenue of last year

SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ — Lunit (KRX: 328130.KQ), a global provider of AI-powered cancer solutions, today announced strong financial results for the second quarter of the fiscal year 2022.

“Through a strong overseas performance in the first half of this year, Lunit achieved more than 80% of last year’s total sales within the first half of 2022,” said Brandon Suh, CEO of Lunit. “With more partnerships to come and the annual health examination season coming up in the third and fourth quarters, we expect our revenue to increase significantly during the second half of the year.”

Reporting under a consolidated basis, Lunit recorded a cumulative revenue of KRW 5.48 billion for the first half of 2022, reaching 82.5% of total sales for the previous year. H1 revenue for 2022 more than tripled compared to the same prior-year period (KRW 1.42 billion) and the proportion of overseas sales jumped from 66.8% to 84.3% year-over-year.

Lunit’s second quarter 2022 revenue was KRW 2.51 billion, up 190% from the prior-year period (KRW 863 million), among which overseas revenue accounted for 80.6%.

H1 Fiscal 2022 Summary

KRW in
millions

H1 2022

Revenue
proportion

H1 2021

Y/Y

Total revenue

5,478

100 %

1,402

Up 291%

Overseas

4,619

84.3 %

937

Up 393%

Domestic

859

15.7 %

465

Up 84.7%

About Lunit

Lunit is a medical AI software company devoted to developing AI solutions for precision diagnostics and treatment support, mainly focused on conquering cancer.

Lunit has partnered with global medical device giants such as GE Healthcare, Philips, and FujiFilm. The company also focuses on its biomarker business through an exclusive partnership with Guardant Health, a leading global liquid biopsy company.

Lunit has earned international recognition for its unprecedented, state-of-the-art AI technology. More than half of its employees are research and development (R&D) specialists, with more than 12 medical doctors working as full-time staff.

Lunit’s flagship products are Lunit INSIGHT and Lunit SCOPE. The FDA-cleared and CE-marked Lunit INSIGHT series provide AI-powered detection of chest abnormalities and breast cancer with 96-99% accuracy. As of March 2022, Lunit INSIGHT products are being used in approximately 600 medical sites in more than 40 countries. Lunit SCOPE series provide AI detection and analytics for tissue data, quantifying key features and scores that enhance elevated response prediction for immunotherapy. By receiving CE Mark in April 2022, Lunit SCOPE PD-L1 TPS has been officially approved for deployment and use in European pathology practices.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lunit-announces-financial-results-for-the-first-half-of-2022-301604990.html

Waterdrop Releases the 2020-21 ESG Report – Striving to Provide High-quality and Sustainable Protection to Billions of Families

BEIJING, Aug. 4, 2022 /PRNewswire/ — Waterdrop Inc. (“Waterdrop”, the “Company” or “we”) (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently released its “2020-21 Environmental, Social and Governance Report” (the “ESG report” or the “report”). This is the first ESG report published since the public offering of Waterdrop. The report unveils the ESG performance of the Company in the areas of corporate governance, social responsibility, technology and innovation, industry value chain, workplace development, green development, and other topics for 2020-21. It also illustrates how Waterdrop leverages its sophisticated business model and technological innovation to resolve various social issues, thereby achieving its effective business performance and sustainable prospects.

Mr. Peng Shen, Founder, Chairman, and Chief Executive Officer of Waterdrop commented, “Since our inception, ESG has been embedded in our corporate mission and business philosophy. The 2020-21 ESG report unveils our continuous efforts to enhance our ESG capabilities, including the provision of online medical fundraising services to approximately 2.4 million patients with critical illnesses through our Waterdrop Medical Crowdfunding platform, and providing inclusive insurance to more than 100 million users whom over 70% are from Tier-3 or lower-tier cities. The report also demonstrates that Waterdrop has attached great weightiness to its ESG-related efforts. Along with our strict compliance with relevant laws and regulations, we have developed rigorous management systems in corporate governance, compliance operations, supplier management, employee management, and low carbon development. At the same time, we have set up a dedicated Social Responsibility Department which empowers our business competitive advantages and technological innovation to integrate resources from various partners, thereby driving sustainable social value. Going forward, we will continue to make every endeavor to promote ESG, striving to achieve our mission of ‘leveraging internet technologies to make insurance protection more inclusive and accessible to the public, and bringing insurance and healthcare services to billions’.”

Business innovation to provide financial relief for medical treatments and prevent patients with critical illness from being impoverished

In early 2021, the State Council published The Opinions of the CPC Central Committee and the State Council on Deepening the Medical Insurance System Reform, proposing that a medical protection system that centers on basic medical insurance, underpinned by medical aid that includes the mutual development of supplemental medical insurance, commercial health insurance, charitable donations, and mutual medical assistance, should be well-established by 2030. Waterdrop leverages its business strengths to provide a solid supplement to China’s multi-layer medical protection system, thereby offering innovative financial assistance solutions for the medical treatments of the needy.

Pioneered from the health protection model of “Waterdrop Medical Crowdfunding (fundraising for patients with critical illnesses)” and “Waterdrop Insurance Marketplace (life and health insurance)” platforms, Waterdrop has utilized its innovative technologies to provide financial relief for the medical treatments of its users, in particular for the low-income group, the marginalized, and the minority communities, thereby improving the efficiency of emergency medical relief. As of the end of 2021, 394 million caring individuals offered medical financial relief of exceeding RMB48.4 billion to patients with critical illnesses and financial difficulties. Waterdrop has highly regarded individuals not covered by traditional insurance, including the low-income group, the elderly, and people with pre-existing medical conditions. The Waterdrop Insurance Marketplace has thus launched various low-threshold, cost-effective, and inclusive insurance products to satisfy the protection needs of these vulnerable groups, such as “Waterdrop Carefree Thyroid Insurance”, “Waterdrop Elderly Medical Insurance”, etc. Currently, out of the over 100 million users on its platform, about three quarters are located in third-tier or lower-tier cities, highlighting the Company’s efforts to improve the penetration rate of health and medical insurance in China.

The financial pressure from the patients to receive medical treatment that are not covered by national medical insurance is also a social issue the general public faces. Through “Waterdrop Medicine”, the Company has provided comprehensive services including healthcare services and diversified medical payment solutions for patients in need of new drugs for special medical purposes, chronic disease drugs, and rare disease drugs. The results relieved the financial pressure on such patients and enhanced the accessibility and affordability of specific medicine. As of the end of 2021, Waterdrop has assisted over 150,000 patients with critical illnesses saving medical expenses of more than RMB50 million.

It is not sufficient to rely on merely one company or a particular business section to utterly resolve a social issue. Henceforth, Waterdrop has integrated various parties to explore more supplementary channels to address the supply of medical relief funds beyond the national medical insurance. The Company is engaged in the establishment of a multi-layer medical protection system and served as a “supplementary layer” through its Waterdrop Medical Crowdfunding, Waterdrop Charity, and other businesses. In March 2021, Jinyun County Healthcare Security Administration of Zhejiang and Waterdrop launched a project named “Jin Qing Bang” to establish a multi-layer medical insurance and poverty prevention system. 5 months after the launch of “Jin Qing Bang“, the platform has helped reduce the out-of-pocket medical expenses of the needy by more than RMB14 million, equivalent to a per capita reduction of over RMB5,000, or a year-over-year decline in such expenses of about 12%. Waterdrop expects the number of people in poverty caused by diseases to reduce by 77% annually. Waterdrop also contributes the export of its technological capabilities for product design, platform construction, marketing and promotion, pharmacy benefit management, and other patient services to empower Hui Min Bao projects for more than 10 cities in mainland China. More than 12 million people have benefited from the low-threshold and high-protection of Hui Min Bao products launched in various cities.

Technological innovations empower the improvement in operational efficiency and promote the development of the healthcare industry

Since its inception, Waterdrop has been consistently investing in R&D to leverage technology to empower its businesses, improve its operational efficiency, and support its service upgrades. In 2021, its R&D expenses increased by 55.2% year-over-year to RMB 379 million, accounting for 11.82% of total revenues. The increase was mainly attributable to the expansion of its R&D team and the strengthening of its technological competitiveness.

Given its in-depth insights into the healthcare industry, Waterdrop unveiled the “ABDC” strategy (AI + Blockchain + Data = Construction), in 2020. Focusing on the application of technologies such as AI and big data analysis in its businesses, Waterdrop has developed its proprietary intelligent systems and tools, including the claims settlement system, “intelligent calculation” system, risk management system, system related to storage media and computing equipment technology, AI-powered matching system, the CONF medical knowledge map, and the intelligent chatbot system, which has improved its operational efficiency and user experience significantly. The Company also took a major step forward by applying for national patents for its inventions and technological innovations.

Meanwhile, the Company has launched Waterdrop Open Platform 2.0, enhancing its capabilities to empower the digitalization, process management, data analytics, and smart operations of the insurance industry.

For marketing insurance products, the AI-powered matching system can match each user with the most appropriate insurance consultants. This applies to users who speak Cantonese, Sichuan Putonghua, or other dialects, thereby improving the APL efficiency of insurance consultants significantly. For insurance claims, Waterdrop’s intelligent claims system is capable of settling a claim in 8 seconds. This has helped save the consumption of 2.61 million paper documents, and the users’ waiting time for claims settlement. The insured people do not need to repeatedly mail paper documents, and do not have to worry about the long hours and complexity of claims settlement. The big data analysis and the CONF medical knowledge map can help generate more accurate estimates of the funds needed for the medical treatment of fundraisers in the Waterdrop Medical Crowdfunding platform, based on information about their illness categories, treatment methods, and the hospitals they attend.

Leveraging technology to effectively drive charitable social value

In 2018, Waterdrop launched an online fundraising platform called Waterdrop Charity, which was later designated by the Ministry of Civil Affairs as one of the online fundraising platforms for charity organizations. Waterdrop Charity has leveraged technology to improve the efficiency of fundraising and fund utilization, providing all-around support for charity organizations. From 2020 to 2021, Waterdrop Charity launched a total of 9,451 projects which cover a wide range of areas including anti-pandemic action, emergency and disaster relief, and rural revitalization, raising a total of RMB833,776,562 from 47,258,209 donators.

During the initial outbreak of the pandemic in 2020, Waterdrop Charity collaborated with over 20 charity organizations and raised more than RMB65 million for the purchase of medical masks, protection gear, and other anti-pandemic supplies. At the same time, Waterdrop Charity joined hands with the China Social Welfare Foundation to launch the “Emergency Response Workers Protection Program”, providing financial relief to frontline medical staff who were infected with or died from Covid-19. Up till now, the program has granted a total of RMB400,000 to four medical workers who contracted the virus, and RMB1 million to the families of two police officers who died on duty, honoring their contribution to the anti-pandemic efforts.

In face of catastrophes, Waterdrop Charity has promptly organized charity projects to integrate the efforts of various parties to distribute relief supplies so that the disaster victims could return to normal life quickly. The Henan Rainstorm Disaster Relief program that Waterdrop Charity launched in 2021 has raised approximately RMB 16.8 million in donations, assisting the transfer and resettlement of more than 209,000 victims. Waterdrop Charity also launched the “Baby Whale Project” to alleviate the financial burden of families whose children suffer from critical illnesses. The project has helped raise more than RMB150 million for the medical expenses of these children from nearly 4.84 million donators, benefiting 1,795 families. Moreover, Waterdrop has initiated the Waterdrop Charity Home program to offer temporary accommodation for patients with critical illnesses and their families during their medical treatment. To date, more than 30 charitable homes have been built in 7 cities across China.

It remains a key focus of Waterdrop to contribute to China’s poverty alleviation and rural revitalization efforts. As a key program to support rural revitalization, the Waterdrop Rural Clinic has built 64 clinics across China, benefiting over 150,000 people in rural areas. Waterdrop is planning to establish 1,000 clinics in 100 counties across the country by 2030, making a greater contribution to rural revitalization and a better China.

Implementing our mission to “put people first and build a better society”

Waterdrop is a company driven by its mission and values. It pursues employee equality and diversity, regarding its employees as partners working for a common cause. Based on this belief, Waterdrop has built an equitable and inclusive workplace with strong growth potential.

Waterdrop promises not to discriminate against employees in recruitment, compensation, training, promotion, and retirement due to differences in gender, race, disability, social class, political affiliation, or any other factors. In 2021, Waterdrop recruited employees from more than 20 ethnic groups, with the proportion of female employees and female managers reaching 46.8% and 28.99%, respectively. Waterdrop also offered customized comprehensive female medical check-up packages, nursing rooms, and breastfeeding leave to its female employees.

For talent training, Waterdrop provides customized training programs for employees in different positions. A comprehensive training system and a variety of training activities are introduced to facilitate all-around growth of every staff, from a new hire to a backbone team member and a leader. In 2021, Waterdrop invested RMB1.69million in employee training, attaining 9,683 participations or an average of 3.3 training sessions for each employee, and achieving a 100% training coverage rate. Meanwhile, Waterdrop has established a clear talent development path and a flexible internal job transfer system for employees’ continued exploration and growth in the suitable positions.

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Waterdrop’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor inquiries, please contact:

Waterdrop Inc.
Xiaojiao Cui
IR@shuidi-inc.com

Christensen
In China
Mr. Eric Yuan
Phone: +86-1380-111-0739
E-mail: Eyuan@christensenir.com

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-releases-the-2020-21-esg-report–striving-to-provide-high-quality-and-sustainable-protection-to-billions-of-families-301600056.html

Source: Waterdrop Inc.

Yunji’s Technology-empowered Private Label SUYE Celebrates Its 12th Anniversary

HANGZHOU, China, Aug. 1, 2022 /PRNewswire/ — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced the celebration of its private-label skin care brand SUYE’s 12th anniversary. SUYE generated over 21 million RMB sales of its high-quality products during its anniversary month of July, including its newly launched GHK-Cu (Copper Glycyl-histidine-tripeptide) multi-effect repairing freeze dried set and polypeptide anti-wrinkle kit. In line with its 12-year development as a socially-conscious brand, SUYE actively participates in charitable activities and contributes to social welfare.

SUYE provides customers with effective and professional products by leveraging its cutting-edge biotechnology and by partnering with top-tier international companies in product development. Since 2016, SUYE has collaborated with a Netherlands-based company, and their joint research revealed the effective anti-aging properties of peptides. Building on this discovery, SUYE has invested extensively in peptide research and developed a wide variety of products that utilize their unique properties. SUYE has gradually implemented product-development strategies that enable its customers to better meet their skin care needs, incorporating professional ingredients typically only utilized in medical aesthetics into its product line. During 2021, SUYE further embraced this approach by launching skin care products that contain ingredients used in mesotherapy treatments. With a research philosophy that emphasizes innovation and application of the latest advances in medical aesthetics, Yunji is committed to providing its customers with safe and effective skincare solutions.

In addition to these successful product developments, SUYE has further committed itself to philanthropic causes. SUYE has partnered with nonprofit dental care provider Future Smile Charitable Foundation, Alibaba’s public welfare group, and other organizations to launch its “Donate for Love” welfare initiative. Donate for Love provides free medical examinations and reconstructive surgery for patients with head and facial deformities, allowing them to smile more confidently.

Shanglue Xiao, Founder and CEO of Yunji, commented, “We are excited by the enthusiastic reception SUYE’s biotechnology-infused products have received from our users. As one of Yunji’s beauty brands’ key private labels, SUYE is synonymous with high-quality products that deliver innovative and effective anti-aging solutions.”

Safe Harbor Statements

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident,” “potential,” “continue” or other similar expressions. Among other things, the quotations from management in this announcement, as well as Yunji’s strategic and operational plans, contain forward-looking statements. Yunji may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about Yunji’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Yunji’s growth strategies; its future business development, results of operations and financial condition; its ability to understand buyer needs and provide products and services to attract and retain buyers; its ability to maintain and enhance the recognition and reputation of its brand; its ability to rely on merchants and third-party logistics service providers to provide delivery services to buyers; its ability to maintain and improve quality control policies and measures; its ability to establish and maintain relationships with merchants; trends and competition in China’s e-commerce market; changes in its revenues and certain cost or expense items; the expected growth of China’s e-commerce market; PRC governmental policies and regulations relating to Yunji’s industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Yunji’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Yunji undertakes no obligation to update any forward-looking statement, except as required under applicable law.

About Yunji Inc.

Yunji Inc. is a leading social e-commerce platform in China that has pioneered a unique, membership-based model to leverage the power of social interactions. The Company’s e-commerce platform offers high-quality products at attractive prices across a wide variety of categories catering to the day-to-day needs of Chinese consumers. In addition, the Company uses advanced technologies including big data and artificial intelligence to optimize user experience and incentivize members to promote the platform as well as share products with their social contacts. Through deliberate product curation, centralized merchandise sourcing, and efficient supply chain management, Yunji has established itself as a trustworthy e-commerce platform with high-quality products and exclusive membership benefits, including discounted prices.

For more information, please visit https://investor.yunjiglobal.com/

Investor Relations Contact

Yunji Inc.
Investor Relations
Email: Yunji.IR@icrinc.com
Phone: +1 (646) 224-6957

ICR, LLC
Robin Yang
Email: Yunji.IR@icrinc.com
Phone: +1 (646) 224-6957

Cision View original content:https://www.prnewswire.com/news-releases/yunjis-technology-empowered-private-label-suye-celebrates-its-12th-anniversary-301596864.html

Source: Yunji Inc.

Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus

SINGAPORE, July 26, 2022 /PRNewswire/ —  Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO).

The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is compatible with common real-time PCR cyclers, such as the Rotor-Gene Q and Applied Biosystems 7500 series platforms. In silico testing shows that the assay is specific for MPXV and has no cross-reactivity with other orthopoxviruses.

“We worked closely with our customers to develop a test that is specifically designed to meet their requirements, making sure that they have a monkeypox-specific assay, with maximum flexibility to choose between manual and automated workflows depending on the number of samples they receive,” said Dr Charlie Lee, Head of Research and Development at Vela Diagnostics.

The monkeypox outbreak has been declared a global health emergency by the World Health Organization (WHO), with over 16,000 cases worldwide. The mode of transmission is thought to be close, sustained physical contact with other people who have monkeypox. The WHO has requested for all countries to provide testing for any individuals that meet the suspected case definition, and to immediately notify it in the case of positive laboratory results.

“Throughout the COVID-19 pandemic, we have worked closely with various testing labs across the globe. We responded quickly to the monkeypox epidemic by allowing research partners and laboratories to offer timely and accurate monkeypox testing,” said Sam Dajani, CEO of Vela Diagnostics and Chairman of the Board. “We have already released the first few batches of kits, and they are being evaluated by our customers globally. We are committed to increasing testing capacity of monkeypox in hopes of containing the spread of the virus.”

For more information; including the IFU, please contact us.

About Vela Diagnostics

Vela Diagnostics is a leading provider for integrated IVD system solutions, from sample to result. VELA’s test solutions utilize the automated SentosaTM platform, providing the unique ability to leverage one system for NGS and PCR testing in infectious disease and oncology.

All Sentosa products listed above are by Vela Diagnostics. For more information, visit www.veladx.com. All other product names, trademarks and logos are the property of their respective owners.

Cision View original content:https://www.prnewswire.com/news-releases/vela-diagnostics-develops-pcr-based-test-for-detecting-monkeypox-virus-301593161.html

Insurance providers can assess customer health risks in real-time using contactless vital sign monitoring solution from NuraLogix

LAS VEGAS, June 29, 2022 /PRNewswire/ — Insurance providers are now able to evaluate customer health risks in real-time using a revolutionary contactless wellness and vital sign monitoring solution from NuraLogix. 

The application allows insurance providers to quickly perform a customer health check during the online interview process using a web-browser. The NuraLogix technology uses a conventional video camera to extract blood flow information from the face, in a patented process called Transdermal Optical Imaging (TOI™), resulting in more than 30+ medical grade health and wellness measurements.

The NuraLogix technology was available for demonstration at the America’s Health Insurance Plans (AHIP) show in Las Vegas, Nevada from June 21 to 23.

The benefits of integrating a vital sign monitoring system into the insurance evaluation process are numerous: reduced costs of underwriting a policy, no nurses needed to conduct physical examinations or take fluid samples, improved compliance with the terms of lower-cost standard policies to avoid price increases, and more. This technology has also been shown to create a ‘Sentinel Effect,’ reducing fraud and improving the accuracy of questionnaire responses.

The Background

Currently in the insurance industry, providers calculate premiums for users, the amount users pay in exchange for coverage. Insurance premiums are based on a wide variety of factors such as age, gender, risk, type of coverage, location, and more. Providers calculate the likelihood the user will need to use the insurance, for example, younger people are less likely to need medical care, so their premiums are generally cheaper. Integrating the NuraLogix technology into the risk evaluation process allows insurers to calculate premiums using accurate health data of the individual and potentially even provide incentives to get healthier.

About AHIP 2022

America’s Health Insurance Plans (AHIP) is the national association of nearly 1,300 members who provide healthcare insurance to more than 200 million Americans. As a national trade association in the health insurance industry, AHIP lobbies to create a more affordable healthcare system through research and policy. Their conference, AHIP 2022, (Formerly ‘Institute & Expo’) brings together the people, ideas, and solutions that guide greater health.

About NuraLogix

NuraLogix’s technology is based on extensive peer-reviewed research and clinical studies, a fact which differentiates them from their competitors. NuraLogix has conducted multiple clinical studies and published research in many notable publications such as Frontiers in Psychology, Scientific Reports, and the Journal of Natural Sciences (JNS). NuraLogix currently holds 11 patents, with more pending. Their impressive client roster includes Japanese systems integration leader NTT Data; Sanitas, the second largest medical insurance company in Spain; and Lafiya Telehealth, a Nigerian-based health telehealth platform which provides 24/7 virtual healthcare services to residents in remote and rural areas.

To Learn More:

Visit our website:
NuraLogix – https://www.nuralogix.ai/  

Disclaimers:

Note: In the United States, this product is for Investigational Use only. The performance characteristics of this product have not been established.

For Media Inquiries: Chris Lin, Chief Marketing Officer, ChrisLin@nuralogix.ai , Tel: 437-928-2666

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

CAMBRIDGE, Mass., and PERTH, Australia, June 28, 2022 /PRNewswire/ —

Summary

The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company specialised in cutting-edge research software for major pharma, biotech, and academic institutions, have partnered to launch IFN Neurologic. This application will help clinicians to better serve patients with neurological disorders and provide treatments in the functional neuroscience domain. The application has been piloted with a limited number of clinics in 2021/2022, and now is made available to clinics and patients worldwide.

IFN Neurologic is an innovative application to help clinicians better serve patients with neurological disorders and provide treatments in the functional neuroscience domain
IFN Neurologic is an innovative application to help clinicians better serve patients with neurological disorders and provide treatments in the functional neuroscience domain

Affiliate Program 

Affiliate clinics will use for the first time IFN Neurologic to perform restorative neuroplasticity interventions on their patients at their own clinic. The affiliate program includes a comprehensive education program accredited by IFN (Institute of Functional Neuroscience) and AICN (Australian Institute of Clinical Neuroscience), all the necessary hardware/software, and access to the IFN Neurologic platform.

The team

Dr. Randy Beck, PhD, Director of the IFN, said: “We’re excited to be launching this new application in partnership with MetaCell. With this new software that requires no installation and can be reached from any web browser in the world, we now have the ability to rapidly scale up our diagnostic processes and reach more patients around the world at the click of a button.”

Giovanni Idili, COO of MetaCell, added: “We are very proud to work with Dr. Beck and provide IFN with a solution that ultimately allows the organisation to help a much greater number of patients at the same outstanding level of service, and we look forward to partnering with many more clinical innovators using our unique approach to custom software development in concert with our clinical neuroscience platforms.”

About IFN

The Institute of Functional Neuroscience (IFN) utilises the latest in neuroplasticity and neuroscience research to develop treatment approaches aimed at improving brain and nervous system performance of patients with a wide range of conditions including migraines, seizure disorders, strokes, attention deficit disorders, obsessive compulsive disorder, developmental coordination delay, vertigo, depression, learning and developmental disorders, concussion syndromes and autism.

About MetaCell

MetaCell is a life science-focused software company composed of scientists and software engineers, with deep domain expertise in computational neuroscience, molecular biology, data science, and enterprise-grade online software development. Their solutions have been trusted for over a decade by some of the world’s largest pharmaceutical companies and leading research institutions in the USA, UK, Australia, Canada, and Europe, including Biogen, Pfizer, Eisai, Salk, UCL, Mount Sinai, UCSD, Yale, Princeton, and many more.

Contact details

IFN Neurologic: https://ifnneurologic.com/ | +61 (08) 6254 2282 | affiliateprogram@ifnneurologic.com
IFN: https://ifn.net.au | +61 (08) 6254 2282 | info@ifn.net.au 
MetaCell: https://metacell.us/ | US +1 617-286-4832 | UK +44 1865 648684 | info@metacell.us

Stryker’s debut at World Intelligence Congress: Bringing Stryker’s Advanced Digital Healthcare to China

SHANGHAI, June 24, 2022 /PRNewswire/ — Stryker (NYSE:SYK), a leading medical technologies company, attended the 6th World Intelligence Congress (WIC) in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market. This is the first time for Stryker to participate in WIC as a strategic partner in healthcare industry, marking a significant milestone for Stryker as it brings more Advanced Digital Healthcare solutions to the China market.

Statistical Communiqué of The People’s Republic of China on the 2021 National Economic and Social Development shows that over 14.2% of the population, or 200,000,000 people are aged 65 and above, increased by 0.7% compared with that in 2020. The aging population in China presented ever pressing demands for China’s health industry, in which digital technology has a key role to play in achieving “health inclusivity” and “cost reduction and efficiency improvement.”

Stryker has a centralized technology organization called Digital, Robotics, and Enabling Technologies (DRE), dedicated to accelerating innovations across the enterprise.  By enabling its innovative products with digital capabilities, Stryker is generating insights to drive improved clinical, operational and financial outcomes across the patient care pathway.


“We are in the world of specialization focused on each stage of the patient care pathway from transport to diagnosis to planning and the OR, to recovery and monitoring, and then rehab and follow up,” says Robert Cohen, President of Digital, Robotics, and Enabling Technologies at Stryker. “We are keen to bring more of our Advanced Digital Healthcare solutions to China.”

One of the highlights of our Advanced Digital Healthcare breakthroughs is Mako SmartRobotics™, a highly advanced robotics technology that transformed the way total knee, partial knee and hip replacements are performed. Mako is able to provide a personalized surgical plan based on your unique anatomy and allow doctors to cut less by cutting precisely. Mako is poised to play a bigger role in making healthcare available for more patients in China through 5G technology. In China, Stryker also provides digital MedSurg solutions in endoscopy: – 1688 andPinPoint, instruments: Core2.0 and Signature and Sonopet, Hololens – Hololens glasses and HI-Integrated surgery room solution.


“China is the second largest healthcare market in the world, and we have been witnessing booming digital healthcare development here. We are committed to working with local partners to bring more technologies to realization and benefit Chinese patients,” says Greg Holman, President of Stryker China.

Stryker has over 85 global digital solutions that span the patient care pathway. We are dedicated to bringing the “best of Stryker” to customers in China, a strategic market for Stryker’s global strategy. Stryker continues to live up to its promise of “grow with China” as it plays a leading role in digital innovation, introducing Advanced Digital Healthcare—innovation that empowers outcomes to China. Stryker is committed to developing healthcare solutions that fit the local market, and expand local partnerships to build an enabling ecosystem. We’re passionate about digital innovation and helping our customers deliver improved outcomes—today and tomorrow.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/strykers-debut-at-world-intelligence-congress-bringing-strykers-advanced-digital-healthcare-to-china-301574632.html